Home · Pipeline ·


  • Therapy
    CF PharmTech is dedicated to the development of products for the treatment of respiratory diseases.
    • Rhinitis is defined as irritation and inflammation of the nasal mucosa. Common symptoms are nasal congestion, runny nose and sneezing. 
    • Asthma is a common chronic inflammatory disease of the airways characterized by variable and recurring symptoms such as reversible airflow obstruction and bronchospasm. Common symptoms are wheezing, cough, chest pain, and shortness of breath.
    • Chronic Obstructive Pulmonary Disease(COPD) is a chronic obstructive pulmonary disease characterized by airflow limitation that worsens over time. The primary symptoms are shortness of breath, cough and sputum production. Most patients with chronic bronchitis have COPD.
    • Respiratory infection is an inflammation of the mucous membranes in your respiratory system (nose, mouth and airways) caused by a virus or bacteria. There are two types of respiratory infections: 
      Upper respiratory infections
      Lower respiratory infections.
    • Pulmonary fibrosis is a serious, lifelong lung disease. It causes lung scarring (tissues scar and thicken over time), making it harder to breathe.
    • Pulmonary hypertension is a condition that affects the blood vessels in the lungs. It develops when the blood pressure in your lungs is higher than normal. About 1% of people globally have pulmonary hypertension. Pulmonary hypertension makes the heart work harder than normal to pump blood into the lungs.

    • Other Respiratory Diseases  

  • Product&Pipeline
    CF PharmTech is leveraging its technological advantages to focus on the key areas of respiratory disease. It is constantly expanding to meet therapeutic needs for respiratory and other diseases through research and development, and cooperation with partners.
    • To deliver a precisely metered amount of the solutions, suspensions or emulsions through a pre-metered or metered-dose spray pump. 
    • An active  pharmaceutical ingredient (API) and expicient mixing with a propellant in the form of a solution, suspension, or emulsion is packaged into container under pressure and delivered to the lungs  via a metering valve system connected to an actuator. The fine mist with drug being delivered with the aid of the propellant during oral inspiration. 
    • Solid active pharmaceutical ingredient alone or mixed with suitable carriers, packaged in capsules, blisters, or multi-dose reservoirs, which is delivered to the lungs by oral inhalation using an inhaler.
    • Water-based formulations intended for nebulizers that produce continuous inhalation aerosols, including inhalation solution and inhalation suspension.
    • Nasal sprays are generally water-based formulations that are applied to the nasal cavity.
    • Spherical vesicles formed  by encapsulating drugs in a lipid bilayer.
  • Medicines
    Inhalation product development is a combination of multiple technical platforms covering pharmacology, pharmacokinetics, particle dynamics, fluid dynamics, surface science, inhaler design, etc., aiming to overcome more challenges compared to other generic products.

    Commercialized products are Budesonide Inhalation Suspension, Salbutamol Sulfate Inhalation Solution, Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray. 

    Learn more
  •  Medicines
  • Health care
    We are committed to providing integrated healthcare solutions that meet the needs of healthcare providers and their patients.
    Learn more
  • Health care